Click here to view the End TB 2018 Abstract Book
Stop TB Session
Progress and Challenges towards Ending TB in a Politically Charged Era
Dr. Mario Raviglione, Geneva, Switzerland
Implementation Science – Rationale and Application to TB Research in Low-Income Settings
Dr. Adithya Cattamanchi, University of California San Francisco, San Francisco, CA, USA
Programmatic Uptake of Novel Treatments for Multidrug-Resistant TB: A Failure of Innovation?
Dr. Jennifer Furin, Harvard University, Boston, MA, USA
Update from TB Alliance Clinical Studies
Dr. Daniel Everitt, TB Alliance, New York, NY, USA
George Comstock Lecture
Programmatic and Clinical Issues Arising from National Tuberculosis Prevalence Surveys: “All We Know About TB is Wrong”
Dr. Phil C. Hopewell, Francis Curry International TB Center, San Francisco, CA, USA
Nursing-Sponsored Session
Engaging TB Patients/Survivors to Support One Another and Educate Community Leaders and Decision Makers
Ms. Terasa Rugg and Ms. Liz Stapf, TB Photovoice, Seattle, WA, USA
Meeting Communication Challenges of TB Patients in Illinois
Ms. Elaine Darnall and Ms. Janette Candido, Illinois Department of Public Health, Chicago, IL, USA
A New Tool for the Toolbox: The Patient LTBI Treatment Decision Aid
Dr. John Parmer, Centers for Disease Control, Atlanta, GA, USA
Community Engagement among Inuit in Nunavut: Lessons from the Field
Dr. Gonzalo Alvarez, University of Ottawa, Ottawa, ON, Canada
Disseminating TB Control Messages to New Networks in North America and Around the World
Ms. Debra Daugherty, Stop TB USA, Washington, DC, USA
Whole Genome Sequencing and Drug Resistance
The Nix-TB Trial: Genotypic-Phenotypic DST Correlations and Identification of Reinfection in Trials
Dr. Daniel Everitt, TB Alliance, New York, NY, USA
Treatment of INH Resistant TB
Dr. Dick Menzies, McGill University, Montreal, QC, Canada
Use of Whole Genome Sequencing of Mycobacteria as a First Line Diagnostic Clinical Service in England
Prof. Tim Peto, University of Oxford, Oxford, UK
Using WGS to Drive TB Elimination in a Low-Incidence Setting
Dr. Jennifer Gardy, BC Centre for Disease Control, Vancouver, BC, Canada
Beyond TB Lecture
Climate Change and Human Health
Dr. Donald Wuebbles, University of Illinois, Urbana, IL, USA
Pediatric and Perinatal TB
TB and Infertility
Dr. Dina Fisher, Alberta Health Services, Calgary, AB, Canada
Diagnosing and Treating Tuberculosis in Pregnant Women: Current Practices and Research Opportunities
Dr. Jyoti Mathad, Center for Global Health/Weill Cornell University, New York, NY, USA
Comparison of the TST and IGRAs in Diagnosing Tuberculosis Infection and Predicting Progression to Tuberculosis Disease in Children
Dr. Amina Ahmed, Levine Children’s Hospital, Charlotte, NC, USA
The 2018 AAP Red Book: New Recommendations for Childhood Tuberculosis
Dr. Jeffrey R. Starke, Baylor College of Medicine, Houston, TX, USA
Current Status of Drugs Used in Treatment of MDR-TB in Children
Prof. Simon Schaaf, Stellenbosch University, Cape Town, South Africa
TB Elimination: Measurements and Outcomes
Latent TB Cascade of Care
Dr. Dick Menzies, McGill University, Montreal, QC, Canada
Dynamics of Tuberculosis in the United States: A Closer Look at Heterogeneity on the State Level
Dr. David Dowdy, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
TB Elimination: Indicators in the United States
Dr. Pennan Barry, University of California San Francisco, San Francisco, CA, USA
Using the LTBI Cascade of Care in Public Health and Primary Care Clinics
Dr. Michelle Haas, Denver Public Health, Denver, CO, USA
Special Lecture
Developing a Human Rights-Based Approach to TB
Mr. Brian Citro, Northwestern Pritzker School of Law, Chicago, IL, USA
TB and Non-Communicable Diseases
Diabetic Immunopathy and TB
Dr. Hardy Kornfeld, University of Massachusetts Medical School, Worcester, MA, USA
TB and Smoking
Dr. Jonathan Golub, Johns Hopkins School of Medicine, Baltimore, MD, USA
TB and Alcohol Use
Dr. Karen Jacobson, Boston University School of Medicine, Boston, MA, USA